I never buy small bio techs on earnings (like clda and ZIOP) I buy them on the potential of being purchased by a whale Their costs related to R & D etc are to be expected They now have enough to carry them well into 2012. They have a lot of good stuff in the pipeline. Good enough that they can get partnered with big Pharmas or better yet , Bought out ! They are losing far less per share in 2010 than in 2009. If it dips early I will buy. I doubt it will take long to run back up. That is if it dips at all.
It is likely that the lower price recently already factored in the news.
Market Data 
Markets 
AI
